Emcure Pharmaceuticals Ltd Share Price (EMCURE)
as on
| Source : NSE
Emcure Pharmaceuticals Ltd Stock Performance
as on August 22, 2025 at 4:01 PM IST
Day's Low
Day's High
₹1,468.1₹1,502.1
1.67%
Downside
0.60%
Upside
52 Week's Low
52 Week's High
₹889₹1,58040.46%
Downside
5.82%
Upside
| Market Stats | |
| Previous Close | ₹1,470.00 |
| Open | ₹1,470.00 |
| Volume | 65.30K |
| Upper Circuit | ₹1,617.00 |
| Lower Circuit | ₹1,323.00 |
| Day's Low | ₹1,468.1 |
| Day's High | ₹1,502.1 |
| 52 Week Low | ₹889 |
| 52 Week High | ₹1,580 |
| Returns % | |
| 1 Month Return | + 4.76 % |
| 3 Month Return | + 16.25 % |
| 1 Year Return | + 7.79 % |
| 3 Year Return | + 9.86 % |
| 5 Year Return | + 9.86 % |
Emcure Pharmaceuticals Ltd Stock Fundamentals & Key Indicators
Check Emcure Pharmaceuticals Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹28,295.49 Cr
Return on Equity (ROE)
12.79
PE Ratio (TTM)
38.05
Return on capital employed (ROCE)
14.36
Industry PE ratio
43.63
Beta (LTM)
1.19
P/B Ratio
6.72
Dividend Yield
0.28
PEG Ratio
3.47
Quarterly Earnings Growth YOY
40.76
EPS (TTM)
37.34
Sector
Pharmaceuticals
Book Value
234.65
Technical Analysis
Bullish
View Technical Analysis
Emcure Pharmaceuticals Ltd Stock's Interest Amongst Investors
Emcure Pharmaceuticals Ltd Stock Valuation
Track how Emcure Pharmaceuticals Ltd P/E has moved over time to understand its valuation trends.
Emcure Pharmaceuticals Ltd in the last 5 years
Lowest (24.97x)
April 9, 2025
Today (38.05x)
August 22, 2025
Industry (43.63x)
August 22, 2025
Highest (53.98x)
September 18, 2024
Today’s Price to Earnings Ratio: 38.05x
Emcure Pharmaceuticals Ltd Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Emcure Pharmaceuticals Ltd.
based on 4 analysts
75.00%
Buy
25.00%
Hold
0.00%
Sell
75% of analysts recommend a 'BUY' rating for Emcure Pharmaceuticals Ltd. Average target price of ₹1652.5
Source: S&P Global Market Intelligence
Emcure Pharmaceuticals Ltd Share Price Target
Get share price movements and forecasts by analysts on Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd price forecast by 4 analysts
Upside of10.68%
High
₹1740
Target
₹1652.50
Low
₹1550
Emcure Pharmaceuticals Ltd target price ₹1652.5, a slight upside of 10.68% compared to current price of ₹1493.1. According to 4 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Emcure Pharmaceuticals Ltd revenue growth forecast
Expected growth rate Q1, FY2027:0
Forecast
Actual
Including amortisation and stock based compensations
Emcure Pharmaceuticals Ltd EPS growth forecast
EPS estimate Q1, FY2027:0
Forecast
Actual
Source: S&P Global Market Intelligence
Emcure Pharmaceuticals Ltd Financial Results
Get the annual and quarterly financial summary of Emcure Pharmaceuticals Ltd, including revenue, profit, loss and more.
Emcure Pharmaceuticals Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd Earnings Results
Emcure Pharmaceuticals Ltd’s net profit jumped 43.64% since last year same period to ₹206.95Cr in the Q1 2025-2026. On a quarterly growth basis, Emcure Pharmaceuticals Ltd has generated 9.52% jump in its net profits since last 3-months.
Read More about Earnings ResultsEmcure Pharmaceuticals Ltd Dividends May,2025
In the quarter ending March 2025, Emcure Pharmaceuticals Ltd has declared dividend of ₹3.00 per share on 22 May 2025 - translating a dividend yield of 0.20%.
Read More about Dividends
Indices Featuring Emcure Pharmaceuticals Ltd Stock
Check stock indices that include Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd Stock Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Emcure Pharmaceuticals Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 77.91% | ||
| Foreign Institutions | 2.86% | ||
| Mutual Funds | 2.34% | ||
| Retail Investors | 16.39% | 5.26 | |
| Others | 0.5% |
Emcure Pharmaceuticals Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Emcure Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 28,295.49 | 1.97% | 0.63 | 707 | 7,896 | |
| NA | 355.90 | -5.99% | 0.69 | 5 | 1,684 | |
| NA | 140.63 | 16.77% | 0.84 | 7 | 339 | |
| NA | 13.76 | -2.08% | 0.00 | -6 | 11 | |
| NA | 979.15 | 294.15% | 0.74 | 7 | 1 |
Emcure Pharmaceuticals Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Reports Strong Q1 Profit Growth - 07 Aug, 2025
Emcure Pharmaceuticals announced a 40.76% rise in Q1 profit to ₹215 crore, supported by robust growth in both domestic and international markets. The company also expanded its partnership with Sanofi, enhancing its position in the metabolic segment.Emcure Partners with Sanofi for Diabetes Drug Distribution - 16 Jul, 2025
Emcure Pharmaceuticals has entered an exclusive agreement with Sanofi India to distribute and promote oral anti-diabetic drugs, including Amaryl and Cetapin, enhancing patient access across India.Emcure's Oncology Plant Passes FDA Inspection - 09 Jul, 2025
Emcure Pharmaceuticals announced that the US FDA completed a pre-approval inspection at its oncology plant in Sanand, Ahmedabad, with no Form 483 issued, indicating full compliance.
Insights on Emcure Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 15.57% to 16.39% in Jun 2025 quarter
- POSITIVE IMPACT
Price Rise
In the last 6 months, EMCURE stock has moved up by 52.4%
NEGATIVE IMPACTMF Holding Down
Mutual Funds have decreased holdings from 2.73% to 2.34% in Jun 2025 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 77.92% to 77.91% in Jun 2025 quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 3.07% to 2.86% in Jun 2025 quarter
About Emcure Pharmaceuticals Ltd
Revenue: ₹2,100.54Cr as on June 2025 (Q1 FY26)
Net Profit: ₹214.79Cr as on June 2025 (Q1 FY26)
Listing date: 10 Jul, 2024
| Organisation | Emcure Pharmaceuticals Ltd |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Mutual Funds that own Emcure Pharmaceuticals Ltd Stock
Check out the Mutual Funds with significant holdings in Emcure Pharmaceuticals Ltd.
FAQs
What is Emcure Pharmaceuticals Ltd share price today?
Emcure Pharmaceuticals Ltd share price today stands at ₹1493.1, Open: ₹1470, Previous Close: ₹1470, High: ₹1502.1, Low: ₹1468.1, 52 Week High: ₹1580, 52 Week Low: ₹889 as on .
How to buy Emcure Pharmaceuticals Ltd shares ?
To buy Emcure Pharmaceuticals Ltd shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for EMCURE or Emcure Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Emcure Pharmaceuticals Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is today's traded volume of Emcure Pharmaceuticals Ltd?
Today's traded volume of Emcure Pharmaceuticals Ltd is 65.30K. Which means that 65.30K shares of Emcure Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.
What is Emcure Pharmaceuticals Ltd's market cap today?
Today's market capitalisation of Emcure Pharmaceuticals Ltd is ₹28,295.49 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Emcure Pharmaceuticals Ltd?
Emcure Pharmaceuticals Ltd’s 52 week high is ₹1580 and 52 week low is ₹889. The current share price of Emcure Pharmaceuticals Ltd is ₹1493.1, which is -5.50% down from its 52 week high and 67.95% up from its 52 week low.